Company News For Dec 27, 2017

• Shares of Mallinckrodt Public Limited Company rallied 0.7% after it announced that it had agreed to buy Sucampo Pharmaceuticals, Inc. for $1.2 billion which also includes debt
• Portola Pharmaceuticals, Inc. plummeted 10.7% after it announced that the FDA had increased its review period by 90 days for a biologics license application for the company’s AndexXa product
• Capital One Financial Corporation’s (COF - Free Report) shares tanked 0.6% after the company reduced its amount of authorized share repurchases following Fed’s instructions
• Shares of Fortress Investment Group LLC (FIG - Free Report) declined 0.3% after the company purchased 4% stakes in Theranos — on the verge of bankruptcy, in return of a $100 million loan

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>